← Open Payments lookup

EMILY NEWMAN: Open Payments

NPI 1629784251 · NEWPORT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,456 in 76 payments from 14 companies in 2025. Trend: 2023 $560 · 2024 $857 · 2025 $1,456

Food & beverage: $1,456
CompanyPaymentsAmount
ABBVIE INC.17$321
Janssen Pharmaceuticals, Inc12$218
Vanda Pharmaceuticals Inc.9$194
E.R. Squibb & Sons, L.L.C.9$176
Otsuka America Pharmaceutical, Inc.10$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$75
Teva Pharmaceuticals USA, Inc.5$73
Axsome Therapeutics, Inc.3$65
Neurocrine BioSciences, Inc.2$44
Alkermes, Inc.1$35

Products named: VRAYLAR, INVEGA SUSTENNA, COBENFY, FANAPT, ABILIFY ASIMTUFII, REXULTI, HETLIOZ, CAPLYTA.

Industry payments across AR — which companies pay providers there.